# Xeris Biopharma Holdings, Inc. (XERS) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $292M |
| 2024 | $203M |
| 2023 | $164M |
| 2022 | $110M |
| 2021 | $50M |
| 2020 | $20M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $83M |
| 2025-09-30 | $74M |
| 2025-06-30 | $72M |
| 2025-03-31 | $60M |
| 2024-09-30 | $54M |
| 2024-06-30 | $48M |
| 2024-03-31 | $41M |
| 2023-09-30 | $48M |
| 2023-06-30 | $38M |
| 2023-03-31 | $33M |
| 2022-09-30 | $30M |
| 2022-06-30 | $25M |
| 2022-03-31 | $22M |
| 2021-09-30 | $11M |
| 2021-06-30 | $9M |
| 2021-03-31 | $8M |
| 2020-09-30 | $9M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/XERS/revenue)